Skip to main content
Advanced Technical IVT

pubertal blockers

Medications that temporarily suppress puberty, primarily used for transgender youth and in cases of precocious puberty.

Full Definition

Pubertal blockers, medically known as gonadotropin-releasing hormone (GnRH) agonists, are medications that temporarily halt pubertal development by suppressing the release of sex hormones. In adolescent medicine, they are used for transgender and gender-diverse youth to prevent unwanted pubertal changes while allowing time for psychological development and decision-making about future medical interventions. The treatment is considered reversible, with pubertal development resuming when the medication is discontinued. Clinical protocols require careful psychological assessment, family involvement considerations, and ongoing monitoring.

Usage

Usage note: Distinguish from hormone replacement therapy; emphasize reversible nature in clinical documentation.

In Context

  • "The multidisciplinary team recommended pubertal blockers following comprehensive psychological evaluation." — Treatment plan
  • "Informed consent for pubertal blockers includes discussion of reversible effects and bone density monitoring." — Consent documentation

Also known as

GnRH agonists puberty suppression therapy

Don't confuse with

hormone replacement therapy cross-sex hormones

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON